nodes	percent_of_prediction	percent_of_DWPC	metapath
Pefloxacin—TOP2A—malignant glioma	0.787	1	CbGaD
Pefloxacin—CYP1A2—Carmustine—malignant glioma	0.196	1	CbGbCtD
Pefloxacin—Enoxacin—TOP2A—malignant glioma	0.00127	0.238	CrCbGaD
Pefloxacin—Lomefloxacin—TOP2A—malignant glioma	0.000963	0.18	CrCbGaD
Pefloxacin—Levofloxacin—TOP2A—malignant glioma	0.000823	0.154	CrCbGaD
Pefloxacin—Ofloxacin—TOP2A—malignant glioma	0.000823	0.154	CrCbGaD
Pefloxacin—Ciprofloxacin—TOP2A—malignant glioma	0.000795	0.149	CrCbGaD
Pefloxacin—Norfloxacin—TOP2A—malignant glioma	0.000668	0.125	CrCbGaD
Pefloxacin—TOP2A—Gastric Cancer Network 1—H3F3A—malignant glioma	0.000513	0.0458	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—STMN1—malignant glioma	0.000367	0.0328	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—POR—malignant glioma	0.000329	0.0294	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—malignant glioma	0.000322	0.0288	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BDKRB2—malignant glioma	0.000316	0.0282	CbGpPWpGaD
Pefloxacin—CYP1A2—Xenobiotics—CYP2B6—malignant glioma	0.000279	0.0249	CbGpPWpGaD
Pefloxacin—TOP2A—Gastric Cancer Network 1—NOTCH1—malignant glioma	0.000268	0.0239	CbGpPWpGaD
Pefloxacin—TOP2A—Gastric Cancer Network 1—APC—malignant glioma	0.000262	0.0234	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—malignant glioma	0.000255	0.0227	CbGpPWpGaD
Pefloxacin—CYP1A2—Xenobiotics—CYP2C18—malignant glioma	0.000242	0.0216	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—malignant glioma	0.000241	0.0215	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—NTRK3—malignant glioma	0.000235	0.021	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—ASMT—malignant glioma	0.000201	0.018	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000196	0.0175	CbGpPWpGaD
Pefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000183	0.0163	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—malignant glioma	0.000182	0.0162	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—TUBG2—malignant glioma	0.000157	0.014	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000148	0.0133	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—malignant glioma	0.000144	0.0129	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000141	0.0126	CbGpPWpGaD
Pefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—malignant glioma	0.00014	0.0125	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TUBG2—malignant glioma	0.00014	0.0125	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—malignant glioma	0.000139	0.0125	CbGpPWpGaD
Pefloxacin—TOP2A—Gastric Cancer Network 2—MYC—malignant glioma	0.000136	0.0122	CbGpPWpGaD
Pefloxacin—TOP2A—Gastric Cancer Network 2—EGFR—malignant glioma	0.000133	0.0119	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000125	0.0112	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.000124	0.0111	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—CYP2C18—malignant glioma	0.000124	0.0111	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—PML—malignant glioma	0.00012	0.0108	CbGpPWpGaD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000116	0.0104	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000114	0.0102	CbGpPWpGaD
Pefloxacin—TOP2A—Gastric Cancer Network 2—TP53—malignant glioma	0.000112	0.01	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—malignant glioma	0.000109	0.0097	CbGpPWpGaD
Pefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.0001	0.00898	CbGpPWpGaD
Pefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	9.92e-05	0.00886	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	9.4e-05	0.00839	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	8.92e-05	0.00797	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS1—malignant glioma	8.81e-05	0.00787	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	8.76e-05	0.00782	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—NTRK1—malignant glioma	8.57e-05	0.00765	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	8.56e-05	0.00764	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	8.53e-05	0.00762	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	8.29e-05	0.00741	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	8.22e-05	0.00735	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	8.15e-05	0.00728	CbGpPWpGaD
Pefloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—malignant glioma	7.74e-05	0.00691	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—NCOR1—malignant glioma	7.49e-05	0.00669	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	7.47e-05	0.00667	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—PLK1—malignant glioma	7.19e-05	0.00642	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—HIST1H3B—malignant glioma	7.12e-05	0.00636	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—CAT—malignant glioma	6.78e-05	0.00606	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	6.67e-05	0.00596	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	6.44e-05	0.00575	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—PLK1—malignant glioma	6.43e-05	0.00574	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—HIST1H3B—malignant glioma	6.37e-05	0.00569	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—malignant glioma	6.21e-05	0.00554	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	6.17e-05	0.00552	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTT1—malignant glioma	5.98e-05	0.00534	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	5.98e-05	0.00534	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	5.98e-05	0.00534	CbGpPWpGaD
Pefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	5.84e-05	0.00522	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	5.79e-05	0.00517	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	5.72e-05	0.00511	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—H3F3A—malignant glioma	5.5e-05	0.00491	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—PPARG—malignant glioma	5.37e-05	0.00479	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—YWHAE—malignant glioma	5.3e-05	0.00473	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP2B6—malignant glioma	4.99e-05	0.00446	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	4.92e-05	0.0044	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—H3F3A—malignant glioma	4.92e-05	0.00439	CbGpPWpGaD
Pefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	4.91e-05	0.00439	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	4.87e-05	0.00435	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—YWHAE—malignant glioma	4.74e-05	0.00423	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	4.63e-05	0.00413	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	4.56e-05	0.00407	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	4.54e-05	0.00406	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	4.5e-05	0.00402	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	4.4e-05	0.00393	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	4.33e-05	0.00387	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	4.27e-05	0.00381	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—malignant glioma	4.21e-05	0.00376	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	4.15e-05	0.0037	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	4.08e-05	0.00365	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—malignant glioma	3.98e-05	0.00356	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	3.83e-05	0.00343	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	3.76e-05	0.00336	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	3.74e-05	0.00334	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	3.73e-05	0.00333	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—PTEN—malignant glioma	3.68e-05	0.00329	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	3.61e-05	0.00322	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—BRCA2—malignant glioma	3.59e-05	0.00321	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDKN2B—malignant glioma	3.56e-05	0.00318	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTT1—malignant glioma	3.5e-05	0.00313	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	3.46e-05	0.00309	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—malignant glioma	3.43e-05	0.00307	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	3.38e-05	0.00302	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	3.36e-05	0.003	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	3.35e-05	0.00299	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—PTGS1—malignant glioma	3.28e-05	0.00293	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.19e-05	0.00285	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.12e-05	0.00278	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—BIRC5—malignant glioma	3.07e-05	0.00274	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TERT—malignant glioma	2.98e-05	0.00266	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.97e-05	0.00265	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.94e-05	0.00263	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	2.84e-05	0.00254	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.7e-05	0.00242	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.62e-05	0.00234	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	2.62e-05	0.00234	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	2.56e-05	0.00229	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	2.56e-05	0.00229	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—TP53—malignant glioma	2.51e-05	0.00224	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—RTEL1—malignant glioma	2.45e-05	0.00219	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	2.44e-05	0.00218	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	2.44e-05	0.00218	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTP1—malignant glioma	2.43e-05	0.00217	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	2.42e-05	0.00216	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	2.39e-05	0.00214	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—malignant glioma	2.28e-05	0.00203	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.21e-05	0.00197	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDKN2A—malignant glioma	2.04e-05	0.00182	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MDM2—malignant glioma	1.97e-05	0.00176	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	1.75e-05	0.00157	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	1.7e-05	0.00152	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—malignant glioma	1.54e-05	0.00138	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—COX8A—malignant glioma	1.41e-05	0.00126	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MYC—malignant glioma	1.38e-05	0.00123	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.26e-05	0.00113	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ASMT—malignant glioma	1.2e-05	0.00107	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.17e-05	0.00105	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TP53—malignant glioma	1.13e-05	0.00101	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—BCAN—malignant glioma	1.13e-05	0.00101	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—IDH2—malignant glioma	9.08e-06	0.000811	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	8.56e-06	0.000765	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP2B6—malignant glioma	8.54e-06	0.000762	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—IDH1—malignant glioma	7.81e-06	0.000697	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SPHK1—malignant glioma	7.55e-06	0.000675	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP2C18—malignant glioma	7.4e-06	0.000661	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.98e-06	0.000623	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.36e-06	0.000568	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.13e-06	0.000548	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTT1—malignant glioma	5.99e-06	0.000535	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PTGS1—malignant glioma	5.61e-06	0.000501	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.59e-06	0.000499	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—BCHE—malignant glioma	5.21e-06	0.000466	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SLC5A5—malignant glioma	5.15e-06	0.00046	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.87e-06	0.000435	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.83e-06	0.000431	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.21e-06	0.000376	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTP1—malignant glioma	4.15e-06	0.000371	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CAT—malignant glioma	4.04e-06	0.000361	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NCOR1—malignant glioma	3.81e-06	0.000341	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CAV1—malignant glioma	3.11e-06	0.000278	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.97e-06	0.000265	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.83e-06	0.000253	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PPARG—malignant glioma	2.73e-06	0.000244	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.49e-06	0.000222	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.17e-06	0.000194	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PTGS2—malignant glioma	2.15e-06	0.000192	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PTEN—malignant glioma	1.87e-06	0.000167	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.32e-06	0.000118	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—AKT1—malignant glioma	1.08e-06	9.65e-05	CbGpPWpGaD
